Morpheus8 Fractional RF Microneedling

De La Cruz Plastic Surgery Houston offers Morpheus8, an FDA-cleared fractional radiofrequency microneedling device with gold-plated insulated needles that deliver controlled RF energy into the deep dermis and superficial subdermal tissue. Morpheus8 penetrates up to 4 mm on the face and 6 mm on the body, remodelling collagen and fat in a way that may support skin tightening and contour improvement. The technology is colour-blind and suitable for all skin tones. It treats skin laxity, fine lines, acne scars, enlarged pores, stretch marks, and sun damage. Three sessions are typically recommended at four-to-six-week intervals, with initial results visible within days and peak improvement at three to four weeks post-treatment.

Morpheus8 at De La Cruz Plastic Surgery Houston represents the intersection of microneedling and radiofrequency energy delivery — combining the collagen-induction benefits of percutaneous needling with the deep thermal remodelling achievable through fractional RF. The Morpheus8 device uses a matrix of twenty-four gold-plated insulated micro-pins that penetrate the skin to a preset depth, where each needle tip emits bipolar RF energy into a spherical zone of thermal influence within the dermis and superficial subdermal tissue. The insulation of the needles' shafts ensures that the thermal energy is deposited at the tip — in the deep dermis and fat interface — rather than dissipating superficially into the epidermis, achieving a deep remodelling effect without surface ablation or prolonged downtime. On the face, pin depths of up to 4 mm target the full dermal thickness including the deep dermis where collagen fibres are densest; on the body, depth extends to 6 mm to access the junction between the deep reticular dermis and superficial subcutaneous fat, enabling a degree of subdermal fat remodelling alongside collagen synthesis that is not achievable with shallower needling devices. The thermal injury created at each pin-tip depth initiates an immediate coagulative response in the dermal collagen network — fibres contract by up to thirty percent acutely, tightening the skin matrix immediately — followed by a phased wound-healing cascade lasting eight to twelve weeks during which fibroblasts synthesise new type I and type III collagen. This dual mechanism of immediate contraction and sustained neocollagenesis accounts for the progressive improvement observed over several months. The system uses SARD (Synchronised Acquisition of Radiofrequency Data) technology to monitor tissue impedance in real time during treatment, modulating RF delivery to maintain a consistent energy dose regardless of tissue variation — an engineering feature that also makes it one of the few devices validated for safe use across Fitzpatrick skin types I through VI without increased risk of post-inflammatory hyperpigmentation. At De La Cruz Plastic Surgery Houston, Morpheus8 is deployed for facial skin laxity, periorbital rhytids, nasolabial fold softening, acne scar remodelling, enlarged pore treatment, stretch marks, and body contouring of the abdomen, arms, and knees where mild to moderate skin redundancy is present. A standard protocol of three sessions spaced four to six weeks apart is recommended, with maintenance sessions annually. Redness and mild swelling subside within one to three days; patients may wear makeup within twenty-four hours. The treatment complements the practice's surgical offerings, providing a non-surgical pathway for patients who are not yet surgical candidates or who wish to maintain results between procedures.